IL6 and myeloid sarcoma: Subjects with higher levels of hs-CRP (≥1.00 mg/L) and IL-6 (≥1.50 pg/mL) or a lower level of adiponectin (<7.90 μg/mL) had a significantly greater risk of MS after adjusting for age, gender, and triglyceride level.